Deanna L. Kirkpatrick

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 24,640,000 shares of common stock of Melinta Therapeutics, Inc., including…

Davis Polk advised the Province of New Brunswick in connection with the offering of $500 million aggregate principal amount of 3.625% bonds due February 24, 2028. The Davis Polk team…

Davis Polk advised the representatives of the several underwriters in connection with the registered offering of £250 million aggregate principal amount of 2.750% senior notes due 2025. DXC…

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 2.750% U.S. dollar bonds due 2023 issued by Export Development Canada…

Davis Polk advised the underwriters in connection with the SEC-registered offering of $1.25 billion aggregate principal amount of 3.300% bonds due March 15, 2028, issued by the Province of…

Davis Polk advised the joint book-running managers in connection with the $80 million public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on the NASDAQ…

Davis Polk advised the underwriters in connection with the offering of $3 billion aggregate principal amount of 2.550% bonds due February 12, 2021 issued by the Province of Ontario.  …

Davis Polk advised the underwriters in connection with the offering by the Province of Ontario of CAD1 billion aggregate principal amount of its 2.65% bonds due February 5, 2025. The net…

Davis Polk advised the joint book-running managers in connection with the $133.7 million initial public offering of common stock of Solid Biosciences Inc. The common stock is listed on the…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1 billion aggregate principal amount of its 2.550% senior notes due 2021 and (ii) $500 million…